
Viraferonpeg 80mcg Injection
Marketer
MSD Pharmaceuticals Pvt Ltd
Salt Composition
Pegylated Interferon Alpha 2B (80mcg)
Overview Viraferonpeg 80mcg Injection
Peg-interferon alfa-2b 80 mcg injection treats chronic hepatitis C (HCV). Administration is solely by a healthcare professional via injection. Treatment duration depends on individual response and is determined by your physician; adhere strictly to their instructions. Incorrect usage or overdose can have severe consequences. Benefits may take weeks or months to appear; discontinue only under medical guidance. Common side effects include headache, nausea, vomiting, dizziness, and sleep disturbances. This medication can lower blood cell counts, increasing infection risk; report fever, chills, rash, breathing difficulties, unusual bleeding/bruising, or dark urine immediately. Regular blood tests monitor blood cell counts, thyroid, liver, kidney function, and electrolytes. Disclose any pre-existing liver, kidney disease, or mental health conditions before starting treatment. Report mood changes, depression, vision problems, or suicidal thoughts to your doctor. Inform your healthcare provider of all other medications you're taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners during treatment.
Primary Ingredients of Viraferonpeg 80mcg Injection
No text provided to rephrase.
Uses of Viraferonpeg 80mcg Injection
Persistent infection with the hepatitis C virus (HCV)
Major Benefits of Viraferonpeg 80mcg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Viraferonpeg 80mcg Injection:
- Abdominal pain
- Agitation
- Anxiety
- Blurred vision
- Cough
- Decreased appetite
- Decreased white blood cell count
- Depression
- Dizziness
- Dryness in mouth
- Fatigue
- Headache
- Impaired concentration
- Indigestion
- Insomnia (difficulty in sleeping)
- Nausea
- Nervousness
- Sore throat
- Stomatitis (Inflammation of the mouth)
- Viral infection
- Vomiting
How to use Viraferonpeg 80mcg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Viraferonpeg 80mcg Injection works:
Peginterferon alfa-2a 80mcg injection influences the body's immune response.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Viraferonpeg 80mcg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Viraferonpeg 80mcg Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Peginterferon alfa-2a 80mcg injection is likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with its use.
DrivingUNSAFE
Administering Viraferonpeg 80mcg Injection may induce adverse reactions impacting driving capabilities. Dizziness, cognitive impairment, drowsiness, and tiredness are potential side effects; therefore, patients should refrain from operating vehicles.
KidneyUNSAFE
The use of Viraferonpeg 80mcg Injection is potentially hazardous for individuals with kidney disease and should be avoided. Medical advice is recommended. Patients with reduced kidney function require careful monitoring when considering this medication.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 80mcg Viraferonpeg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Viraferonpeg 80mcg Injection :
Should you forget a Viraferonpeg 80mcg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Viraferonpeg 80mcg Injection
Label | Value |
---|---|
Chemical Type | Interferon proteins |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Actions | Interferon proteins |